🔎 Trials Near Me

Dachaigh › Ailse Endometrial › Illinois

Sgrùdaidhean clionaigeach Ailse Endometrial ann an Illinois

Tha 38 sgrùdaidhean airson Ailse Endometrial a’ lorg phàirtichean aig làraichean ann an Illinois.

Bailtean ann an Illinois

Teacsa sgrùdaidh oifigeil (Beurla)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • Northwestern University, Chicago
  • Rush MD Anderson Cancer Center, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
  • agus 26 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 5 Dàmh 2026 · NCT07198074

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Advocate Good Shepherd Hospital, Barrington
  • Illinois CancerCare-Bloomington, Bloomington
  • Illinois CancerCare-Canton, Canton
  • agus 57 a bharrachd
A’ fastadhÌre 2
Gach aois · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564377

A Study of PHST001 in Advanced Solid Tumors

  • University of Chicago Medical Center, Chicago
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06840886

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

  • University of Chicago Comprehensive Cancer Center, Chicago
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Dàmh 2026 · NCT05950464

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • University of Illinois Cancer Center, Chicago
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06172478

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • University of Chicago, Chicago
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT05051722

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • Carle at The Riverfront, Danville
  • Carle Physician Group-Effingham, Effingham
  • Carle Physician Group-Mattoon/Charleston, Mattoon
  • agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 28 Sult 2026 · NCT05112601

DESTINY-PANTUMOUR04

  • Research Site, Decatur
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07124000

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, Chicago
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06218914

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • Northwestern University, Chicago
  • Northwestern Medicine Orland Park, Orland Park
  • Northwestern Medicine Cancer Center Warrenville, Warrenville
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 24 Sult 2026 · NCT05640999

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
  • University of Chicago Medical Center, Chicago
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 24 Sult 2026 · NCT04590326

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Northwestern University Feinberg School of Medicine, Chicago
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT05983432

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

  • OSF Saint Francis Medical Center, Peoria
  • Carle Cancer Institute, Urbana
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 17 Sult 2026 · NCT06340568

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • City of Hope, Chicago, Zion
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • University of Illinois Cancer Center, Chicago
  • University of Chicago Medicine, Chicago
  • City of Hope - Chicago, Zion
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  • Endeavor Health NorthShore, Evanston
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 9 Sult 2026 · NCT07166094

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  • Research Site, Arlington Heights
  • Research Site, Evanston
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 3 Sult 2026 · NCT06989112

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • University of Chicago Medical Center, Chicago
A’ fastadhÌre 1
Aoisean 15 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Lurie Children's Hospital-Chicago, Chicago
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  • Northwestern Medicine, Chicago
  • University of Illinois Cancer Center, Chicago
  • University of Chicago Medicine, Chicago
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 21 Lùna 2026 · NCT05548296

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • University of Chicago Medical Center, Chicago
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT04104776

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

  • St. Francis Medical Center (OSF Healthcare), Peoria
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07470853

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Orchard Healthcare Research Inc, Skokie
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT06330064

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

  • St. Francis Medical Center (OSF Healthcare), Peoria
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT07444814

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Hope and Healing Cancer Services, Hinsdale
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Chicago
  • Research Site, Peoria
  • Research Site, Urbana
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Iuch 2026 · NCT07044336

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

  • Northwestern University, Chicago
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT05377996

Integrated Cancer Repository for Cancer Research

  • Rush-Copley Cancer Care Center, Aurora
  • Rush-Copley Healthcare Center, Yorkville
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 19 gu 110 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT02012699

A Study of LY4175408 in Participants With Advanced Cancer

  • The University of Chicago Medical Center (UCMC), Chicago
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT07046923

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

  • Northwestern University, Chicago
A’ fastadh
Aoisean 60 agus nas sine · Banairean · Air ùrachadh 29 Cèit 2026 · NCT05743517

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  • University of Chicago Medical Center, Chicago
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT06395519

Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

  • Northwestern Memorial Hospital, Chicago
A’ fastadh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 24 Màrt 2026 · NCT05990426

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

  • Kellogg Cancer Center, Evanston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Samh 2025 · NCT05902988

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chicago
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 80 · Banairean · Air ùrachadh 28 Gearr 2025 · NCT00005095

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

  • Dr. Sudarshan K. Sharma, Ltd., Hinsdale
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Cèit 2024 · NCT05797831

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.